Cannformatics

12/07/2025

Cannformatics: 2025 Highlights

A Year of Recognition, Milestones, & Momentum

12/07/2025

Cannformatics: 2025 Highlights https://wix.to/JLGDt2w
https://wix.to/2FNuEqj

A Year of Recognition, Milestones, & Momentum

11/11/2025

This past Friday, at the 2nd Annual New York State Medical Cannabis Symposium hosted by the NY State Office of Cannabis Management and Northwell Health, we announced that together with Northwell, we'll be conducting a groundbreaking study to evaluate the impact of medical cannabis on the behavioral & psychological symptoms of dementia. Check out the press release and learn more about the study at

Identifying and applying Cannabis-Responsive biomarkers for improving health and quality of life

04/08/2025

We’re excited to share that Cannformatics’ own Ken Epstein is featured in Cannabis Business Times! 🙌

In his latest op-ed, Ken explores how the cannabis industry can better support people managing complex health conditions—while also improving business outcomes—by developing products that meet real patient needs.

At Cannformatics, we’re proud to lead with science, compassion, and a commitment to evidence-based care.

The cannabis industry was built on medical cannabis; now it’s time to return to it.

06/28/2024

The Journal of Anesthesia & Analgesia earlier this year published an editorial, "Cannabis as a Therapeutic or Snake Oil? A Desperate Call for Critical Appraisal of the Literature." We answered the call with a letter to the editor, "Cannabis-Responsive™ Biomarkers: Answering the Call for Critical Appraisal of Medical Cannabis." Check out the abstract to learn how C-Res biomarkers are leading the way in objectively evaluating the impact of medical cannabis on patients with over 80 endocannabinoid system-related disorders.

An abstract is unavailable.

01/31/2024

We're starting off 2024 with momentum! Check out our latest newsletter announcing this week's publishing of our latest paper in the Journal of Neurology & Neuromedicine

Welcoming 2024 with Momentum

08/29/2023

Autism spectrum disorder (ASD) is a neurodevelopmental condition impacting behavior, communication, social interaction and learning abilities. Medical cannabis (MC) treatment can reduce clinical symptoms in individuals with ASD. Cannabis-responsive biomarkers are metabolites found in saliva that cha...

08/24/2023

Today we announced with a press release the publication of our third paper in Nature's Scientific Reports. The press release outlines some of the incredible discoveries we've made towards helping people with take a personalized medicine approach to medical cannabis treatment. Check it out!

Pioneering Research Harnesses Cannabis-Responsive (C-Res™) Biomarkers & Machine Learning to pave the way for Customized Therapies Across a Broad Range of...

08/22/2023

Check out our third paper in Springer Nature Scientific Reports. The paper reveals our groundbreaking progress in personalizing medical treatment for . https://www.nature.com/articles/s41598-023-40073-0

07/25/2023

Our Chief Commercial Officer & Cofounder is speaking on a panel at the California Fair Cannabis Awards in Sacramento this Thursday at 6:30 PM. The topic is Breaking the Stigma: Technology & Innovation in the Cannabis Industry. It is also Military, Veterans and First Responders Day at the fair. All those groups get in free and the panel will cover stigma related to cannabis use for PTSD and other service related injuries.

04/06/2023

Exited to be heading to Portland to present at the Cannabis Science Conference. If you need a ticket check out our discount code.

03/25/2023

Next month Cannformatics CEO & Cofounder Dr. Itzhak Kurek is presenting on the potential of to provide insights on the role of treatment in children with using a Cannabis-Responsive™ Biomarker database at the Cannabis Science Conference, April 19-21, in Portland, OR. You don't want to miss it! Use code FACULTY30 to save 30% on registration.